Literature DB >> 29124952

Current management and treatment of patients with stable coronary artery diseases presenting to cardiologists in different clinical contexts: A prospective, observational, nationwide study.

Leonardo De Luca1, Pier Luigi Temporelli2, Donata Lucci3, Lucio Gonzini3, Carmine Riccio4, Furio Colivicchi5, Giovanna Geraci6, Dario Formigli7, Patrizia Maras8, Colomba Falcone9, Andrea Di Lenarda10, Michele Massimo Gulizia11.   

Abstract

Background Stable coronary artery disease (CAD) is a leading cause of mortality worldwide. Few studies document the complete sequence of investigation of the overall stable CAD population during outpatient visits or hospitalisation. Aim To obtain accurate and up-to-date information on current management of patients with stable CAD. Methods START (STable coronary Artery diseases RegisTry) was a prospective, observational, nationwide study aimed at evaluating the presentation, management, treatment and quality of life of stable CAD patients presenting to cardiologists during outpatient visits or discharged from cardiology wards. Results Over a 3-month period, 5070 consecutive patients were enrolled in 183 participating centres: 72% managed by a cardiologist during outpatient or day hospital visits and 28% discharged from cardiology wards. The vast majority of patients (87%) received a coronary angiography (86% of patients managed during outpatient visits and 90% during hospitalisation; p < 0.0001). Outpatients more frequently received optimal medical therapy (OMT; i.e. aspirin or thienopyridine, β-blockers and statins) compared to hospitalised patients (70.2% vs 67.1%; p = 0.03). A personalised diet was prescribed in 58% (60.5% in outpatients and 52.9% in those admitted to hospitals; p < 0.0001), physical activity programmes were suggested in 65% (69.4% and 54.3%; p < 0.0001) and smoking cessation was recommended in 71% of currently smoking patients (73.2% and 65.2%; p = 0.02). Conclusions In this large, contemporary registry, patients with stable CAD discharged from cardiology wards more commonly underwent diagnostic imaging procedures and less frequently received OMT or lifestyle modification programmes compared to patients manged by cardiologists during outpatient visits.

Entities:  

Keywords:  Stable coronary artery disease; angina; management; quality of life; registry; treatment

Mesh:

Substances:

Year:  2017        PMID: 29124952     DOI: 10.1177/2047487317740663

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  7 in total

1.  Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.

Authors:  Leonardo De Luca; Marcello Arca; Pier L Temporelli; Furio Colivicchi; Lucio Gonzini; Donata Lucci; Biagio Bosco; Mariella Callerame; Giulio V Lettica; Andrea Di Lenarda; Michele M Gulizia
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

2.  Correlation between exercise, personal income level and health-related quality of life in patients with newly diagnosed stable angina.

Authors:  Yi Wang; Lei Huang; Lai-Xin Zhou
Journal:  Mil Med Res       Date:  2019-11-25

3.  Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study.

Authors:  Leonardo De Luca; Pier Luigi Temporelli; Furio Colivicchi; Lucio Gonzini; Maria Luisa Fasano; Massimo Pantaleoni; Gabriella Greco; Fabrizio Oliva; Domenico Gabrielli; Michele Massimo Gulizia
Journal:  Front Cardiovasc Med       Date:  2022-04-13

4.  Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study.

Authors:  Leonardo De Luca; Pier Luigi Temporelli; Donata Lucci; Furio Colivicchi; Paolo Calabrò; Carmine Riccio; Antonio Amico; Franco Mascia; Emanuele Proia; Andrea Di Lenarda; Michele Massimo Gulizia
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

5.  BENEFIT for all: An ecosystem to facilitate sustained healthy living and reduce the burden of cardiovascular disease.

Authors:  Mike Keesman; Veronica Janssen; Hareld Kemps; Monika Hollander; Wilma Scholte Op Reimer; Lisette van Gemert-Pijnen; Arno Hoes; Wessel Kraaij; Niels Chavannes; Douwe Atsma; Roderik Kraaijenhagen; Andrea Evers
Journal:  Eur J Prev Cardiol       Date:  2018-11-28       Impact factor: 7.804

6.  Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries.

Authors:  Furio Colivicchi; Michele Massimo Gulizia; Marcello Arca; Pier Luigi Temporelli; Lucio Gonzini; Vanessa Venturelli; Nuccia Morici; Ciro Indolfi; Domenico Gabrielli; Leonardo De Luca
Journal:  Cardiovasc Ther       Date:  2020-01-03       Impact factor: 3.023

Review 7.  Post-percutaneous coronary intervention angina: From physiopathological mechanisms to individualized treatment.

Authors:  Leonardo De Luca; Giuseppe M C Rosano; Ilaria Spoletini
Journal:  Cardiol J       Date:  2021-04-12       Impact factor: 3.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.